She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
Neurology Consultant Advisory Board Member Rachel Salas, MD, discusses her experiences in caring for her patients with sleep disorders via telemedicine, how medical education is changing for her neurology...
They discuss the benefits and challenges of teleneurology, especially as the COVID-19 pandemic wears on, and how you can start implementing teleneurology into your own practice.
In this podcast, Dominick J. Angiolillo, MD, PhD, provides insight into a new analysis of the TWILIGHT Trial that he and his colleagues performed among high-risk patients with diabetes.
James Matera, DO, explains the interaction between diabetes, cardiovascular disease, and kidney disease, and how the presence of one or more of these conditions can complicate treatment outcomes.
In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about treating patients with cardiovascular disease and diabetes—with a special focus on how to choose the appropriate novel...
He discusses his latest research on how managing lipid levels with the Wahls diet and other integrative interventions affects fatigue related to multiple sclerosis.
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
